SECURITIES AND EXCHANGE COMMISSION
                             Washington, DC 20549

                                  FORM 10-Q

               QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                    OF THE SECURITIES EXCHANGE ACT OF 1934

               For the quarterly period ended December 27, 1998

                       Commission file number: 0-21154

                             CREE RESEARCH, INC.
            (Exact name of registrant as specified in its charter)

                 North Carolina                  56-1572719
        (State or other jurisdiction of        (I.R.S. Employer
         incorporation or organization)       Identification No.)

               4600 Silicon Drive
             Durham, North Carolina                 27703
      (Address of principal executive offices)    (Zip Code)

                                (919) 313-5300
             (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. [ X] Yes [ ] No

The number of shares  outstanding of the  registrant's  common stock,  par value
$0.005 per share, as of January 19, 1999 was 13,004,469.



                             CREE RESEARCH, INC.
                                  FORM 10-Q

                   For the Quarter Ended December 27, 1998

                                    INDEX

                                                                        Page No.

PART I.  FINANCIAL INFORMATION

Item 1. Financial Statements

        Consolidated Balance Sheets at December 27, 1998
        (unaudited) and June 28, 1998                                      3

        Consolidated Statements of Income for the three
        and six months ended December 27, 1998 and
        December 28, 1997 (unaudited)                                      4

        Consolidated Statements of Cash Flow for the six
        months ended December 27, 1998 and December 28, 1997
        (unaudited)                                                        5

        Notes to Consolidated Financial Statements (unaudited)             6

Item 2. Management's Discussion and Analysis of Financial
        Condition and Results of Operations                               13

Item 3. Quantitative and Qualitative Disclosures About Market Risk        21


PART II.  OTHER INFORMATION

Item 4. Submission of Matters to a Vote of Security Holders               21

Item 6. Exhibits and Reports on Form 8-K                                  22


SIGNATURES                                                                23

                                     -2-



PART I - FINANCIAL INFORMATION

Item 1 - Financial Statements


                              CREE RESEARCH, INC.
                          CONSOLIDATED BALANCE SHEETS
                                (In thousands)


                                                        December 27,   June 28,
                                                            1998         1998
                                                        ------------   --------
                                                        (Unaudited)
                                                     
ASSETS

Current assets:
     Cash and cash equivalents                           $ 12,769      $ 17,680
     Marketable securities                                    905           657
     Accounts receivable, net                              12,110        10,479
     Inventories                                            3,402         2,543
     Deferred income tax                                      264         1,952
     Prepaid expenses and other current assets                691         1,347
                                                        ------------   --------
         Total current assets                              30,141        34,658

     Property and equipment, net                           44,972        36,476
     Patent and license rights, net                         1,641         1,525
     Other assets                                           1,349            65
                                                        ------------   --------
         Total assets                                    $ 78,103      $ 72,724
                                                        ============   ========

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
     Accounts payable, trade                              $ 4,097       $ 5,595
     Current maturities of long term debt                     121            17
     Accrued salaries and wages                               550           391
     Other accrued expenses                                   990         1,052
                                                        ------------   --------
         Total current liabilities                          5,758         7,055

Long term liabilities:
     Long term debt                                         9,879         8,650
     Deferred income tax                                    2,477         2,154
                                                        ------------   --------
         Total long term liabilities                       12,356        10,804

Shareholders' equity:
     Preferred stock, par value $0.01; 3,000 shares            --            --
       authorized at December 27, 1998 and 2,750
       shares authorized at June 28, 1998; none
       issued and outstanding
     Common stock, par value $0.005; 30,000 shares             65            65
       authorized at December 27, 1998 and 14,500
       shares authorized at June 28, 1998; shares
       issued and outstanding 12,920 and 12,989 at
       December 27, 1998 and June 28, 1998,
       respectively
     Additional paid-in-capital                            49,583        49,676
     Retained earnings                                     10,341         5,124
                                                        ------------   --------
         Total shareholders' equity                        59,989        54,865
                                                        ============   ========
         Total liabilities and shareholders' equity      $ 78,103      $ 72,724
                                                        ============   ========


              The accompanying notes are an integral part of the
                     consolidated financial statements.

                                     -3-




                               CREE RESEARCH, INC.
                        CONSOLIDATED STATEMENTS OF INCOME
                      (In thousands, except per share data)
                                   (Unaudited)


                                Three Months Ended              Six Months Ended
                            ----------------------------   --------------------------
                            December 27,   December 28,    December 27,  December 28,
                                1998           1997            1998          1997
                            ------------   ------------    ------------  ------------
                                                             
Revenue:
   Product revenue, net       $12,805        $ 8,164         $23,525       $16,369
   Contract revenue, net        1,233          1,942           2,792         3,944
                            ------------   ------------    ------------  ------------
    Total revenue              14,038         10,106          26,317        20,313

Cost of revenue:
   Product revenue              6,377          4,946          11,792        10,365
   Contract revenue             1,045          1,600           2,252         3,252
                            ------------   ------------    ------------  ------------
    Total cost of revenue       7,422          6,546          14,044        13,617
                            ------------   ------------    ------------  ------------

Gross profit                    6,616          3,560          12,273         6,696

Operating expenses:
   Research and development     1,121            527           1,927           920
   Sales, general and           1,450            850           2,668         1,985
     administrative
   Other expense                  298            390             567           390
                            ------------   ------------    ------------  ------------
    Income from operations      3,747          1,793           7,111         3,401

Interest income, net               20            169             135           332
                            ------------   ------------    ------------  ------------
    Income before income        3,767          1,962           7,246         3,733
    taxes
Income tax expenses               916            490           2,029         1,093
                            ------------   ------------    ------------  ------------

    Net income                $ 2,851        $ 1,472       $   5,217       $ 2,640
                            ============   ============    ============  ============

Earnings per share:
    Basic                       $0.22          $0.12          $0.41         $0.21
                            =============  =============   ============  ============
    Diluted                     $0.21          $0.11          $0.39         $0.20
                            =============  =============   ============  ============



                The accompanying notes are an integral part of the
                       consolidated financial statements.

                                     -4-




                              CREE RESEARCH, INC.
                     CONSOLIDATED STATEMENTS OF CASH FLOW
                                (In thousands)


                                                         Six Months Ended
                                                   -----------------------------
                                                   December 27,     December 28,
                                                       1998             1997
                                                   ------------     ------------
                                                           (Unaudited)
                                                              
Operating activities:
     Net income                                       $5,217           $2,640
     Adjustments to reconcile net income to net
       cash provided by operating activities:
     Depreciation and amortization                     2,341            2,067
     Loss on disposal of property, equipment and         951              320
       patents
     Amortization of patent rights                        56               50
     Amortization and write off of goodwill              --                86
     Proceeds from sale of marketable trading            489              -- 
       securities
     Purchase of marketable trading securities         (232)          (1,500)
     Gain on marketable trading securities             (116)             --  
     Changes in operating assets and liabilities:
        Accounts receivable                          (1,964)          (2,258)
        Inventories                                    (859)            1,161
        Prepaid expenses and other assets              1,004              148
        Accounts payable, trade                      (3,073)            (783)
        Accrued expenses                                 420              889
                                                   ------------     ------------
        Net cash provided by operating activities      4,234            2,820
                                                   ------------     ------------

Investing activities:
     Purchase of property and equipment             (10,380)          (5,704)
     Proceeds from sale of property and equipment        189              340
     Purchase of patent rights                         (194)            (200)
                                                   ------------     ------------
        Net cash used in investing activities       (10,385)          (5,564)
                                                   ------------     ------------

Financing activities:
     Proceeds from issuance of long-term debt          1,333            3,259
     Net proceeds from issuance of common stock        2,527            2,139
     Receipt of Section 16(b) common stock profits       594              -- 
     Repurchase of common stock                      (3,214)              -- 
                                                   ------------     ------------
        Net cash provided by financing activities      1,240            5,398
                                                   ------------     ------------

Net (decrease) increase in cash and cash             (4,911)            2,654
  equivalents

Cash and cash equivalents:
     Beginning of period                              17,680           10,448
                                                  =============     ============
     End of period                                  $ 12,769         $ 13,102
                                                  =============     ============

Supplemental disclosure of cash flow information:
     Cash paid for interest, net amounts            $    275         $   --  
       capitalized
                                                  =============     ============
     Cash paid for income taxes                     $  1,396         $    219
                                                  =============     ============


              The accompanying  notes are an integral part of the
                     consolidated financial statements.

                                     -5-



                             CREE RESEARCH, INC.
                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                 (Unaudited)

Basis of Presentation

The  consolidated  balance  sheet as of  December  27,  1998,  the  consolidated
statements  of income for the three and six months  ended  December 27, 1998 and
December  28, 1997,  and the  consolidated  statements  of cash flow for the six
months ended  December 27, 1998 and December 28, 1997 have been  prepared by the
Company and have not been audited. In the opinion of management,  all normal and
recurring  adjustments  necessary  to  present  fairly the  financial  position,
results of  operations  and cash flow at  December  27,  1998,  and all  periods
presented,  have been made.  The balance sheet at June 28, 1998 has been derived
from the audited financial statements as of that date.

Certain  information  and footnote  disclosures  normally  included in financial
statements prepared in accordance with generally accepted accounting  principles
have been condensed or omitted.  It is suggested that these condensed  financial
statements  be read in  conjunction  with the  financial  statements  and  notes
thereto  included  in the  Company's  fiscal  1998 Form  10-K.  The  results  of
operations for the period ended December 27, 1998 are not necessarily indicative
of the operating results that may be attained for the entire fiscal year.

Accounting Policies

Fiscal Year

The Company's fiscal year is a 52 or 53 week period ending on the last Sunday in
the month of June.  Accordingly,  all  quarterly  reporting  reflects  a 13 week
period in fiscal 1999. In fiscal 1998, the Company  changed its fiscal year from
the  twelve  months  ending  June 30, to the 52 week  period  ending on the last
Sunday in the month of June. The Company's  current fiscal year will extend from
June 29, 1998 to June 27, 1999.

Investments

Investments  are  accounted  for  in  accordance  with  Statement  of  Financial
Accounting  Standards No. 115,  "Accounting for Certain  Investments in Debt and
Equity  Securities" ("SFAS No. 115"). This statement requires certain securities
to be classified into three categories:

(a)      Securities  Held-to-Maturity -- Debt securities that the entity has the
         positive  intent  and  ability  to hold to  maturity  are  reported  at
         amortized cost.

                                        -6-



(b)      Trading  Securities -- Debt and equity  securities  that are bought and
         held  principally  for the  purpose  of  selling  in the near  term are
         reported at fair value,  with  unrealized  gains and losses included in
         earnings.

(c)      Securities   Available-for-Sale  --  Debt  and  equity  securities  not
         classified as either securities  held-to-maturity or trading securities
         are reported at fair value with  unrealized  gains and losses  excluded
         from  earnings  and reported as a separate  component of  stockholders'
         equity.

The Company's short-term investments are comprised of equity securities that are
classified  as trading  securities,  which are carried at their fair value based
upon quoted market prices of those  investments  at December 27, 1998,  with net
realized and unrealized gains and losses included in net earnings.

As of December 27, 1998, short-term investments consist of common stock holdings
in C3, Inc.  ("C3"),  the majority of which were  purchased in November 1997 and
September 1998. The Company's CEO has, through a binding agreement,  promised to
indemnify  the  Company  for  losses of up to  $450,000  for the net  difference
between the aggregate cash  consideration  paid by the Company for the shares of
C3 common stock and the cash  proceeds  received by the Company upon the sale of
C3 common stock.  This indemnity  covers losses that may result from the sale of
shares  purchased in November 1997 and September  1998 below the purchase  price
paid,  offset by gains realized on shares  acquired  directly from C3 in January
1997 (see  below).  Payment  of this  obligation  is due  within  ten days after
receipt by the CEO of the  Company's  written  demand made pursuant to a vote of
the  majority  of the  members  of the Board of  Directors  other  than the CEO.
Realized  losses on shares of C3 stock sold by the  Company  were  $254,000  and
$46,000,  for fiscal 1998 and 1999,  respectively.  At December  27, 1998, a net
unrealized  gain,  including  shares acquired  directly from C3 (see below),  of
$383,000  was  recognized  to bring  the  valuation  of shares  held to  market.
Therefore,  approximately $120,000 and $116,000 of other income was recorded for
the three and six months ended  December 27, 1998,  respectively.  Approximately
$32,000 of net losses were  recorded to other  income  (expense) in fiscal 1998.
Since the net unrealized gain on shares held exceeded  realized losses on shares
sold, there was no receivable recorded from the CEO as of December 27, 1998.

In addition to the shares of C3 purchased in November 1997 and  September  1998,
the Company  acquired  24,601 shares of C3 common stock in January  1997.  These
shares were issued  pursuant to an option C3 granted to the Company in 1995. The
option gave the Company the right to acquire, for an aggregate  consideration of
$500, one percent of the  outstanding  common stock of C3. C3 retained the right
to waive the  consideration and issue the stock at any time, which it elected to
do in January  1997.  The shares  issued  pursuant to the option are  restricted
securities  within  the  meaning of Rule 144 under the  Securities  Act of 1933,
which  permits  the sale of such  securities  without  registration  if  certain
conditions are met. The shares first became  eligible for sale under Rule 144 in
the third quarter of fiscal 1998.

                                     -7-



Long Term Debt

The Company  obtained a term loan from a commercial bank of up to $10,000,000 to
finance  the  purchase  and  upfit of a  production  facility  and  service  and
warehouse  buildings  in  November  1997.  As of  December  27,  1998 the entire
$10,000,000 loan was outstanding,  including a current portion of $121,000 and a
long  term  amount  of  $9,879,000.  The loan,  which is  collateralized  by the
purchased property, accrues interest at a fixed rate of 8% and carries customary
covenants,  including the maintenance of a minimum  tangible net worth and other
requirements.  Accrued interest is due monthly until May 1999, at which time the
outstanding  principal  balance will be amortized  over twenty years until 2011,
when the loan balance becomes due.

During the three and six months ended December 27, 1998, the Company capitalized
interest on funds used to construct property,  plant and equipment in connection
with the  facility.  Interest  capitalized  for the three and six  months  ended
December 27, 1998 was $34,000 and $118,000, respectively.

Inventories

Inventories  are  stated at the lower of cost or  market,  with cost  determined
under  the  first-in,  first-out  (FIFO)  method.  Inventories  consist  of  the
following:



                                         December 27,         June 28,
                                             1998               1998
                                         ------------       ------------
                                                 (In thousands)
                                                      
             Raw materials                 $ 1,338             $ 999
             Work-in-progress                1,220               752
             Finished goods                    844               792
                                         ------------       ------------
             Total Inventory               $ 3,402           $ 2,543
                                         ============       ============



Research and Development Accounting Policy

The U.S.  Government  provides  funding  for  several of the  Company's  current
research  and  development  efforts.  The  contract  funding  may be  based on a
cost-plus or a cost-share arrangement. The amount of funding under each contract
is  determined  based on cost  estimates  that  include  direct  costs,  plus an
allocation for research and development,  general and administrative and cost of
capital  expenses.  Cost-plus funding is determined based on actual costs plus a
set percentage  margin. For cost-share  contracts,  the actual costs are divided
between the U.S.  Government and the Company based on the terms of the contract.
The government's  cost share is then paid to the Company.  Activities  performed
under these arrangements  include research regarding silicon carbide and gallium
nitride  materials.  The  contracts  typically  require  submission of a written
report to document the results of such research.

                                     -8-



The revenue and expense classification for contract activity is determined based
on the nature of the contract.  For contracts where the Company anticipates that
funding  will  exceed  direct  costs over the life of the  contract,  funding is
reported  as  contract  revenue  and all direct  costs are  reported as costs of
contract revenue.  For contracts under which the Company anticipates that direct
costs will exceed amounts to be funded over the life of the contract,  costs are
reported as research and  development  expenses and related funding as an offset
of those expenses.  The following table details  information about contracts for
which  direct  expenses  exceed  funding by period as included  in research  and
development expenses:



                            Three Months Ended             Six Months Ended
                       December 27,   December 28,    December 27,  December 28,
                           1998           1997            1998          1997
                       ------------   ------------    ------------  ------------
                                              (In thousands)
                                                        
Net R&D costs             $  -            $ 161           $ -           $ 281
Government funding           -              311             -             598
                       ============   ============    ============  ============
Total direct costs        $ -             $ 472           $ -           $ 879
  incurred
                       ============   ============    ============  ============



As of  December  27,  1998,  all  funding  under  contracts  where  the  Company
anticipates  that  direct  costs  will  exceed  amounts  to be  funded  has been
exhausted.  Therefore,  the Company  anticipates  that all future  funding under
existing contracts will be reflected as contract revenue while direct costs will
be reported as contract cost of revenue.

Significant Sales Contract

In September 1996, the Company entered into a Purchase Agreement with Siemens AG
("Siemens"),  pursuant to which  Siemens  agreed to purchase LED chips made with
the Company's gallium  nitride-on-silicon  carbide technology. In April 1997 and
December  1997,  contract  amendments  were  executed that provided for enhanced
product  specifications  requested  by Siemens and larger  volume  requirements,
respectively.

In  September  1998,  the Company and Siemens  further  amended the  contract to
extend the Purchase  Agreement  with respect to shipments to be made on or after
June 29, 1998. The third amendment obligates the Company to ship, and Siemens to
purchase,  stipulated  quantities of both the conductive buffer and the new high
brightness  LED chips and  silicon  carbide  wafers  through  fiscal  1999.  The
agreement  also limits  Siemens'  right to defer  shipments  to 30% of scheduled
quantities  for items to be shipped in more than 24 weeks after  initial  notice
and 10% of  scheduled  quantities  for items to be shipped in more than 12 weeks
after  initial  notice.  In both cases,  Siemens would be required to accept all
product  within  90  days  of the  original  shipment  date.  Additionally,  the
amendment  provides  for  higher  per unit  prices  early in the  contract  with
reductions in unit prices as the cumulative volume shipped increases.

In  December  1998,  the Company and  Siemens  further  amended the  contract to
include greater  quantities of conductive  buffer LED chips to be shipped during
fiscal 1999 and to extend the

                                     -9-



contract  for these  shipments  through  September  1999.  This  amendment  also
provides  for higher per unit prices early in the contract  with  reductions  in
unit prices as the cumulative volume shipped increases. As was the case with the
third  amendment,  these higher prices were  negotiated by the Company to offset
higher per unit costs expected earlier in the contract.

Income Taxes

The Company has  established an estimated tax provision  based upon an effective
rate of 28%. The estimated tax rate was based on tax reduction  strategies being
implemented  by the  Company.  The  estimated  effective  rate  was  based  upon
projections  of income for the fiscal year and the Company's  ability to utilize
remaining net operating loss carryforwards and other tax credits.  However,  the
actual effective rate may vary depending upon actual pre-tax book income for the
year or other factors.

Deferred tax assets and liabilities are recognized for the estimated  future tax
consequences  attributable to differences  between financial  statement carrying
amounts of  existing  assets and  liabilities  and their  respective  tax bases.
Deferred  tax assets and  liabilities  are measured  using  enacted tax rates in
effect for the year in which  those  temporary  differences  are  expected to be
recovered or settled.

The actual income tax expense  attributable to earnings for the six months ended
December  27,  1998  differed  from the amounts  computed  by applying  the U.S.
Federal tax rate of 35% to pretax earnings as a result of the following:



                                                      Amount         Percent
                                                  --------------  --------------
                                                  (In thousands)
                                                           
Federal income tax provision at statutory rate      $ 2,536            35.0%
State tax provision                                     174             2.4
Decrease in income tax expense resulting from:
      Foreign sales corporation                       (306)           (4.2)
      State tax incentives                            (167)           (2.3)
      Research and development credits                 (85)           (1.2)
      Change in valuation allowance                   (123)           (1.7)
                                                  --------------  --------------
Income tax expense                                  $ 2,029            28.0%
                                                  ==============  ==============


The following  are the  components of the provision for income taxes for the six
months ended December 27, 1998 (in thousands):

                                     -10-



      Current:
            Federal                               $ 1,182
            State                                     175
                                                 ---------
      Total Current Portion                         1,357
      Deferred:
            Federal                                   782
            State                                   (110)
                                                 ---------
      Total Deferred Portion                          672
      Net Provision                               $ 2,029
                                                 =========

The tax effects of temporary  differences that give rise to significant portions
of the deferred tax assets and deferred tax liabilities are as follows:



                                           December 27,       June 28,
                                               1998             1998
                                           -------------    ------------
                                                  (In thousands)
                                                      
Deferred tax assets:
Net operating loss carryforwards             $  948            $1,304
Research tax credits                             92               169
Compensation accruals                            70                62
Inventory capitalization                        130               120
Bad debt allowance                               64                56
Alternative minimum tax                         158               261
Foreign tax credit                              153               270
State incentive credits                         165                --
                                           -------------    ------------
Total gross deferred tax assets               1,780             2,242
Less valuation allowance                      (167)             (290)
                                           -------------    ------------
Net deferred tax asset                        1,613             1,952

Deferred tax liabilities:
Property and equipment, due to                2,477             2,154
  depreciation
                                           -------------    ------------
Gross deferred tax liabilities                2,477             2,154
                                           -------------    ------------
Net deferred tax asset (liability)           $(864)            $(202)
                                           =============    ============



The net  change  in the  total  valuation  allowance  for the six  months  ended
December  27, 1998 was  $123,000.  The primary  reason for the  reduction in the
valuation  allowance  for  the  six  months  ended  December  27,  1998  was the
implementation  of tax  strategies  to  utilize  these  assets.  Realization  of
deferred tax assets  associated with the NOL carryforwards is dependent upon the
Company generating sufficient taxable income prior to their expiration. Although
realization  is not assured for the  remaining  deferred tax assets,  management
believes it is more likely  than not that they will be realized  through  future
taxable earnings.  However,  the net deferred tax assets could be reduced in the
future if  management's  estimates  of taxable  income  during the  carryforward
period are significantly reduced.

                                     -11-



As of December 27, 1998,  the Company has net operating loss  carryforwards  for
federal   purposes  of  $3,493,000  and  $2,346,000  for  state  purposes.   The
carryforward expiration period is 2011 to 2013 for federal tax purposes and from
2000 to 2003 for state  purposes.  The  Company  anticipates  that each of these
carryforwards will be utilized by the end of the current fiscal year.

Earnings Per Share

The  Company  presents  earnings  per  share in  accordance  with  Statement  of
Financial  Accounting Standards No. 128, "Earnings Per Share" ("SFAS 128"). SFAS
128  required  the  Company to change its method of  computing,  presenting  and
disclosing  earnings per share information.  All prior period data presented has
been restated to conform to the provisions of SFAS 128.

The  following  computation  reconciles  the  differences  between the basic and
diluted presentations:



                                        Three Months Ended               Six Months Ended
                                    December 27,    December 28,    December 27,   December 28,
                                        1998           1997             1998           1997
                                    ------------    ------------    ------------   ------------
                                             (In thousands, except per share amounts)
                                                                       
Net income                            $ 2,851         $ 1,472         $ 5,217        $ 2,640
Weighted average common shares         12,832          12,789          12,876         12,699
                                    ------------    ------------    ------------   ------------
Basic earnings per common share       $ 0.22          $ 0.12          $ 0.41          $ 0.21
                                    ============    ============    ============   ============


Net income                            $ 2,851        $ 1,472          $ 5,217        $ 2,640

Diluted weighted average common
  shares:
Common shares outstanding              12,832         12,789          12,876          12,699
Dilutive effect of stock options        1,002            847             665             823
  and warrants
                                    ------------    ------------    ------------   ------------
Total diluted weighted average         13,834         13,636          13,541          13,552
common shares
                                    ------------    ------------    ------------   ------------
Diluted earnings per common share     $ 0.21          $ 0.11           $0.39          $ 0.20
                                    ============    ============    ============   ============



Potential common shares that would have the effect of increasing  diluted income
per share are considered to be antidilutive.  In accordance with SFAS 128, these
common shares were not included in calculating  diluted income per share.  As of
December 27, 1998, there were no potential shares considered to be antidilutive.
For the three and six months ended December 28, 1997,  there were 300,000 shares
that were not included in  calculating  diluted  income per share  because their
effect was antidilutive.

                                     -12-



New Accounting Pronouncements

In fiscal 1999, the Company adopted Statement of Financial  Accounting Standards
No. 130,  "Reporting  Comprehensive  Income"  ("SFAS  130"),  which  establishes
standards for reporting and display of  comprehensive  income and its components
in a full set of  general-purpose  financial  statements.  SFAS 130 only impacts
financial  statement  presentation as opposed to actual amounts recorded.  Other
comprehensive  income includes all nonowner  changes in equity that are excluded
from net  income.  This  Statement  has no  financial  statement  impact  for an
enterprise  that  has no  items  of other  comprehensive  income  in any  period
presented.  During the three and six months ended December 27, 1998 and December
28, 1997, the Company had no items of other comprehensive income.

In fiscal 1999, the Company adopted Statement of Financial  Accounting Standards
No. 131,  "Disclosures about Segments of an Enterprise and Related  Information"
("SFAS  131").  SFAS  131  changes  the  way  public  companies  report  segment
information in annual financial  statements and also requires those companies to
report  selected  segment   information  in  interim  financial   statements  to
shareholders.  SFAS 131 also establishes standards for related disclosures about
products and services, geographic areas, and major customers. The application of
the new rules  does not have a  significant  impact on the  Company's  financial
statements.

In June 1998, the Financial Accounting Standards Board issued Statement No. 133,
"Accounting  for Derivative  Instruments and Hedging  Activities"  ("SFAS 133"),
which is required to be adopted in years beginning after June 15, 1999.  Because
of the Company's minimal use of derivatives, management does not anticipate that
the adoption of the new Statement will have a significant  effect on earnings or
the financial position of the Company.

Item 2.  Management's Discussion and Analysis of Financial Condition and Results
         of Operations

Information set forth in this Form 10-Q, including  Management's  Discussion and
Analysis of Financial  Condition  and Results of  Operations,  contains  various
"forward-looking statements" within the meaning of Section 27A of the Securities
Act of 1933 and  Section 21E of the  Securities  Act of 1934,  which  statements
represent the Company's judgment  concerning the future and are subject to risks
and  uncertainties  that could cause the Company's actual operating  results and
financial position to differ materially.  Such forward-looking statements can be
identified  by the use of  forward-looking  terminology  such as "may,"  "will,"
"anticipate,"  "believe,"  "plan,"  "estimate,"  "expect,"  and  "intend" or the
negative  thereof or other  variations  thereof or comparable  terminology.  The
Company cautions that any such forward-looking  statements are further qualified
by important  factors that could cause the Company's actual operating results to
differ materially from those in the forward-looking  statements,  including, but
not limited to, fluctuations in our operating results,  production yields in our
manufacturing  processes,  whether we can produce commercial  quantities of high
brightness  blue and green LEDs, our  dependence on a few customers,  whether we
can manage our growth effectively,  assertion of intellectual property rights by
others,  adverse economic conditions,  and insufficient  capital resources.  See
Exhibit  99.1 for  additional  factors  that could  cause the  Company's  actual
results to differ.

                                     -13-



Overview

Cree  Research,  Inc.  is the  world  leader  in  developing  and  manufacturing
semiconductor  materials  and  electronic  devices  made  from  silicon  carbide
("SiC").  We recognize  product revenue at the time of shipment or in accordance
with the terms of the relevant  contract.  We derive the largest  portion of our
revenue from the sale of blue and green light emitting  diode ("LED")  products.
The Company offers LEDs at two  brightness  levels -- high  brightness  blue and
green  products  and  standard  blue  products.  The  Company's  LED devices are
utilized  by end users  for  automotive  backlighting,  liquid  crystal  display
("LCD")  backlighting  (including use in wireless  handsets),  indicator  lamps,
miniature white lights (such as replacements for miniature  incandescent bulbs),
indoor sign and arena  displays,  outdoor full color stadium  displays,  traffic
signals and other lighting applications.

The high brightness  products,  which were introduced to the market in September
1998  in  limited   quantities,   are  currently   being   integrated  into  our
manufacturing  facility  for full  production.  During  the first six  months of
fiscal 1999, margins realized on the high brightness products were substantially
lower than those  derived from our standard  blue LED product,  as the yield was
lower than the standard product.  Historically,  we have experienced low margins
with many new product introductions,  and we are working to make improvements to
output and yield during the second half of fiscal 1999. We  anticipate  that the
high brightness  products will contribute  greater volumes as yield improvements
are obtained.

We believe that in order to increase  market demand for all of our LED products,
we must continue to substantially lower average sales prices.  Historically,  we
have been  successful  in achieving  lower costs for the standard  blue product.
During the remainder of fiscal 1999, we plan to focus on reducing  costs through
higher  production yields and from higher volumes as fixed costs are spread over
a greater number of units.

We also derive  revenue from the sale of advanced  materials  made from SiC that
are used  primarily for research and  development.  We also sell SiC crystals to
C3, which  incorporates them in gemstone  applications.  During late fiscal 1998
and the first six months of fiscal 1999, C3 purchased  equipment  from us, which
has more than doubled the capacity for the production of crystals for C3.

The balance of our revenue is derived from government  contract  funding.  Under
various  programs,  U.S.  Government  entities  further the  development  of our
technology by supplementing our research and development  efforts. All resulting
technology  obtained  through  these  efforts  remains  our  property  after the
completion of the contract,  subject to certain  license rights  retained by the
government. Contract revenue includes funding of direct research and development
costs  and a  portion  of our  general  and  administrative  expenses  and other
operating  expenses  for  contracts  under  which  funding is expected to exceed
direct costs over the life of the  contract.  For  contracts  under which direct
costs are  anticipated  to  exceed  amounts  to be  funded  over the life of the
contract (i.e., certain cost share  arrangements),  direct costs are reported as
research and  development  expenses with related  reimbursements  recorded as an
offset to those expenses.

                                     -14-



On September 24, 1997, the Board of Directors  changed the Company's fiscal year
from the twelve months ending June 30 to a 52 or 53 week year ending on the last
Sunday in the month of June.  The Company's  1998 fiscal year extended from July
1, 1997 to June 28, 1998.

Results of Operations

Three Months Ended December 27, 1998 and December 28, 1997

Revenue.  Revenue  increased  39% from $10.1  million  in the second  quarter of
fiscal 1998 to $14.0 million in the second quarter of fiscal 1999. This increase
was  attributable  to an increase in product revenue of 57% from $8.2 million in
the second  quarter  of fiscal  1998 to $12.8  million in the second  quarter of
fiscal 1999.  This rise in product  revenue was a result of the 128% increase in
sales of our LED products in the second  quarter of fiscal 1999  compared to the
second  quarter  of fiscal  1998.  Growth in LED  volume  was due in part to the
introduction  of the new high  brightness  devices,  but  mostly was a result of
strong  demand for the standard  brightness  product.  This volume  increase was
partly  offset by a 35% decline in the average  sales price of the standard blue
LED chip during this same period.  We believe that in order to increase  volume,
we must continue to lower average sales prices.

Revenue  attributable  to sales of SiC  materials  was 88%  higher in the second
quarter  of  fiscal  1999  than in the  same  period  of  fiscal  1998  due to a
significant increase in sales to C3 for gemstone applications. During the second
quarter of fiscal 1998, C3 was in initial stages of operation;  therefore,  unit
sales were limited. Revenue from sales of SiC wafers increased 48% in the second
quarter of fiscal 1999 as compared to the second  quarter of fiscal 1998, due to
quality  improvements  in  wafers,  along  with the  availability  of the larger
two-inch  wafer during  fiscal 1999.  During the second  quarter of fiscal 1999,
sales from our displays  business  declined 95% over the prior year period as we
have chosen to de-emphasize  this product line.  Contract  revenue received from
U.S.  Government  agencies declined 36% during the second quarter of fiscal 1999
compared to the second  quarter of fiscal 1998, as a  significant  contract that
funded optoelectronic research was exhausted in early fiscal 1999.

Gross Profit.  Gross margin  climbed to 47% of revenue during the second quarter
of fiscal 1999 as compared to 35% during the second quarter of fiscal 1998. This
increase is predominantly  attributable to design and manufacturing improvements
that occurred over the past year  resulting in  significant  reductions in cost.
With the introduction of the new conductive  buffer LED technology in the fourth
quarter of fiscal 1998, we were able to significantly  lower costs of production
due to the fewer  manufacturing  steps  required with the new chip structure and
improved yield.  During the second quarter of fiscal 1998, we began to fabricate
devices on a larger  two-inch  wafer;  however,  we were still in the process of
establishing  this new  manufacturing  design  and had not  achieved  production
efficiency.  In  addition,  the  larger  two  inch  wafer  had not  been in full
production  for much of the period;  therefore,  average  die yields  during the
second  quarter of fiscal  1998 were  significantly  lower.  Wafer costs for SiC
material  sales also declined 21% during the second  quarter of fiscal 1999 over
the comparative period due to more efficient processes and improved yield.

                                     -15-



Research and Development.  Research and development  expenses  increased 113% in
the  second  quarter of fiscal  1999 to $1.1  million  from $0.5  million in the
second quarter of fiscal 1998. Much of this increase was caused by significantly
higher  costs  for the  initial  development  of the  new  high  brightness  LED
products.  We  anticipate  that  internal  funding  for the  development  of new
products  will  continue  to grow in  future  periods,  while  we  believe  that
government  funding  for  our  development  projects  will  remain  constant  or
decrease.

Sales, General and Administrative.  Sales,  general and administrative  expenses
increased  71% in the second  quarter of fiscal 1999 to $1.5  million  from $0.9
million in the second  quarter of fiscal  1998 due  primarily  to two  insurance
events that were  recorded in the second  quarter of fiscal 1998. As a result of
the  dismissal of a securities  class action  lawsuit in November  1997, we were
reimbursed $0.2 million for costs incurred in connection with the lawsuit.  Most
of these expenses were recorded in fiscal 1997. In addition,  we received a $0.2
million  reimbursement  of medical  expenses due to a  negotiated  cost cap in a
partially  self-funded  insured  health  plan.  As a  result  of  our  increased
profitability  during the second  quarter of fiscal 1999 over the second quarter
of fiscal 1998, the profit sharing  accrual (which is based on 5% of net income)
has also  grown $0.1  million.  We  anticipate  that total  sales,  general  and
administrative  costs  will  increase  in  connection  with  the  growth  of our
business;  however,  we believe that as a percentage of revenue they will remain
constant or possibly decline.

Other (Income) Expense. Other expenses have decreased 24% to $0.3 million during
the second  quarter of fiscal 1999 from $0.4  million for the second  quarter of
fiscal 1998. In the second  quarter of fiscal 1999, we realized  impairments  to
leasehold costs as a result of management's  decision to move equipment from our
leased  facility  to our new  manufacturing  site.  This was offset  somewhat by
investment  income  recognized  on stock  held in C3. In the  second  quarter of
fiscal  1998,  we had  written off certain  fixed  assets that were  impaired in
value. These write-downs  exceeded the fiscal 1999 leasehold  write-downs offset
by the investment income.

Interest Income, Net. Interest income, net has decreased 88% to $0.02 million in
the second  quarter of fiscal  1999 from $0.2  million in the second  quarter of
fiscal 1998 due to interest  expense  incurred.  In November 1997, we obtained a
term loan from  NationsBank to fund the acquisition and  construction of our new
manufacturing  facility in Durham, North Carolina.  The majority of the interest
incurred in the second quarter of fiscal 1999 has been expensed.

Income Tax Expense. Income tax expense for the second quarter of fiscal 1999 was
$0.9 million compared to $0.5 million in the second quarter of fiscal 1998. This
increase  resulted from  increased  profitability  during the second  quarter of
fiscal 1999 over fiscal 1998.

Six Months Ended December 27, 1998 and December 28, 1997

Revenue.  Revenue  increased  30% from $20.3  million in the first six months of
fiscal  1998 to $26.3  million  in the first six  months  of fiscal  1999.  This
increase was  attributable  to an increase in product  revenue of 44% from $16.4
million in the first six months of fiscal 1998 to $23.5 million in the first six
months of fiscal  1999.  This rise in product  revenue  was a result of the 128%
increase  in sales of our LED  products  in the first six months of fiscal  1999
compared to

                                     -16-



the first six months of fiscal 1998. Growth in LED volume was due in part to the
introduction  of the new high  brightness  devices,  but  mostly was a result of
strong  demand for the standard  brightness  product.  This volume  increase was
partly  offset by a 40% decline in the average  sales price of the standard blue
LED chip during this same period.  We believe that in order to increase  volume,
we must continue to lower average sales prices.

Revenue  attributable  to sales of SiC  material was 84% higher in the first six
months  of  fiscal  1999  than  in the  same  period  of  fiscal  1998  due to a
significant increase in sales to C3 for gemstone applications.  During the first
six months of fiscal 1998,  C3 was in initial  stages of  operation;  therefore,
unit sales were limited.  Revenue from sales of SiC wafers  increased 43% in the
first six months of fiscal  1999 as  compared  to the first six months of fiscal
1998, due to quality  improvements in wafers, along with the availability of the
larger two-inch wafer during fiscal 1999.  During the first six months of fiscal
1999, sales from our displays  business  declined 96% over the prior year period
as we have chosen to de-emphasize  this product line.  Contract revenue received
from U.S. Government agencies declined 29% during the first six months of fiscal
1999 compared to the first six months of fiscal 1998, as a significant  contract
that funded optoelectronic research was exhausted in early fiscal 1999.

Gross Profit. Gross margin climbed to 47% of revenue during the first six months
of fiscal 1999 as  compared  to 33% during the first six months of fiscal  1998.
This  increase  is  predominantly   attributable  to  design  and  manufacturing
improvements   that  occurred  over  the  past  year  resulting  in  significant
reductions  in cost.  With the  introduction  of the new  conductive  buffer LED
technology in the fourth  quarter of fiscal 1998, we were able to  significantly
lower costs of production due to fewer manufacturing steps required with the new
chip structure and improved  yield.  During the first six months of fiscal 1998,
we  introduced  a smaller  LED chip  size and,  in  December  1997,  we began to
fabricate devices on a larger two-inch wafer. As of December 1997, we were still
in the  process of  establishing  these new  manufacturing  designs  and had not
achieved production  efficiency.  In addition, the larger two inch wafer had not
been in full  production for much of the period;  therefore,  average die yields
during the first six months of fiscal 1998 were significantly lower. Wafer costs
for SiC material  sales also  declined 47% during the first six months of fiscal
1999 over the  comparative  period due to more efficient  processes and improved
yield.

Research and Development.  Research and development  expenses  increased 109% in
the first six months of fiscal  1999 to $1.9  million  from $0.9  million in the
first  six  months  of  fiscal  1998.  Much  of  this  increase  was  caused  by
significantly  higher  costs  for  the  initial  development  of  the  new  high
brightness LED product.  We anticipate that internal funding for the development
of new products will continue to grow in future  periods,  while we believe that
government  funding  for  our  development  projects  will  remain  constant  or
decrease.

Sales, General and Administrative.  Sales,  general and administrative  expenses
increased  34% in the first six months of fiscal 1999 to $2.7  million from $2.0
million in the first six months of fiscal 1998 due  primarily  to two  insurance
events that were  recorded in the second  quarter of fiscal 1998. As a result of
the dismissal of a securities class action lawsuit in November 1997,

                                     -17-



we were  reimbursed  $0.2  million  for costs  incurred in  connection  with the
lawsuit.  Most of these  expenses were recorded in fiscal 1997. In addition,  we
received a $0.2 million  reimbursement  of medical  expenses due to a negotiated
cost cap in a partially  self-funded  insured  health  plan.  As a result of our
increased  profitability  during  the first six  months of fiscal  1999 over the
first six months of fiscal 1998, the profit  sharing  accrual (which is based on
5% of net income) has also grown $0.2 million.  We anticipate  that total sales,
general and administrative  costs will increase in connection with the growth of
our  business;  however,  we believe that as a  percentage  of revenue they will
remain constant or possibly decline.

Other (Income) Expense. Other expenses have increased 45% to $0.6 million during
the first six months of fiscal  1999 from $0.4  million for the first six months
of fiscal 1998. In the first six months of fiscal 1999, we realized  impairments
to leasehold costs as a result of  management's  decision to move equipment from
our leased facility to our new  manufacturing  site. This was offset somewhat by
income recognized under our equipment  build-out  agreement with C3. In 1998, we
sold to C3  equipment  manufactured  by us at cost  plus a  reasonable  overhead
allocation. The overhead allocation was recorded as "Other income."

Interest Income,  Net. Interest income, net has decreased 59% to $0.1 million in
the first six months of fiscal 1999 from $0.3 million in the first six months of
fiscal 1998 due to interest  expense  incurred.  In November 1997, we obtained a
term loan from  NationsBank to fund the acquisition and  construction of our new
manufacturing facility in Durham, North Carolina. While much of the interest was
capitalized  during the last half of fiscal  1998,  the majority of the interest
incurred in the first six months of fiscal 1999 has been expensed.

Income Tax  Expense.  Income tax expense for the first six months of fiscal 1999
was $2.0  million  compared  to $1.1  million  in the first six months of fiscal
1998. This increase resulted from increased  profitability  during the first six
months of fiscal 1999 over fiscal 1998.  Our effective tax rate during the first
six  months of fiscal  1999 was 28%  compared  to 29% in the first six months of
fiscal 1998.

Liquidity and Capital Resources

We have funded our operations to date through sales of equity,  bank  borrowings
and revenue  from product and contract  sales.  As of December 27, 1998,  we had
working capital of approximately $24.4 million,  including $13.7 million in cash
and cash equivalents and marketable securities.

Operating  activities generated $4.2 million in cash during the first six months
of fiscal 1999.  This was  attributable  primarily to net income of $5.2 million
and other non-cash expenses of $3.3 million. These amounts were partly offset by
an  increase of $2.0  million in accounts  receivable,  a $0.9  million  rise in
inventory and a $3.1 million decrease in accounts payable.

Most of the $10.4 million of cash used by investing  activities in the first six
months of fiscal 1999 was related to expenditures  associated with the continued
construction of our new

                                     -18-



manufacturing   facility  in  Durham,   North   Carolina.   We  also   increased
manufacturing  capacity  by  adding  new  equipment  to  support  the  epitaxial
deposition and clean room fabrication processes.

The $1.2  million of cash  provided  by  financing  activities  in the first six
months of fiscal 1999 related  primarily to the receipt of $1.8 million and $0.7
million in proceeds  from the exercise of stock  warrants and stock options from
the  Company's  employee  stock option  plan,  respectively.  In addition,  $0.6
million was received  from a Director as payment of profits  from a  short-swing
transaction in our securities and $1.3 million was funded as the final draw from
the long term debt  arrangement  with  NationsBank.  We  currently  have a $10.0
million loan outstanding from  NationsBank.  We expect to pay off this loan with
the proceeds from our secondary  stock  offering  described in the  registration
statement  on Form S-3 filed by the Company  with the  Securities  and  Exchange
Commission  on January  14,  1999.  These cash  proceeds  were  offset by a $3.2
million  cash  outlay for the  repurchase  of our common  stock.  This stock was
repurchased  at an average price of $13.68.  The stock  warrants  exercised were
distributed in connection  with the Company's  September 1995 private  placement
and have an exercise price of $27.23. As of December 28, 1998, warrants remained
outstanding to purchase 234,575 shares;  these warrants will expire in September
2000.

We are currently engaged in construction  activities related to a new clean room
fabrication  facility.  We also  intend to expand our  facility  for new crystal
growth and test and packaging areas in calendar 1999. These additions will allow
the Company to  consolidate  all LED and wafer  manufacturing  facilities to one
site with improved  manufacturing  capabilities.  In addition,  in order to keep
pace  with  anticipated  growth  in LED and wafer  sales  and  provide  expanded
facilities for our new microwave product line, the Company  anticipates a second
phase of expansion to  facilities  and  infrastructure  to begin in early fiscal
2000.  We  anticipate  total costs for these  expenses to be between $15 and $18
million.  Estimates for equipment  costs related to this expansion total between
$15 and $17 million. We plan to fund these capital projects from the proceeds of
our secondary stock offering. In addition, we are in the process of purchasing a
79-acre site close to our present facility for $1.5 million.  We anticipate that
internally generated cash plus the proceeds of the secondary stock offering will
be sufficient to fund our capital requirements for the next 12 months.

Impact of the Year 2000

State of Readiness

We have  adopted a Year 2000  compliance  plan and formed a team of  information
technology professionals assigned the task of identifying and resolving any Year
2000 issues that may affect our business.  Our compliance  plan has four phases:
inventory,  assessment,  remediation and testing. We have completed an inventory
for all of our computer  systems,  computer related equipment and equipment with
embedded  processors,  as  well  as our  products,  and  are in the  process  of
assessing  those  systems.  We have completed  this  assessment  with respect to
approximately  80% of our systems and expect to complete our  assessment  of the
remaining  systems by February 1999. In addition,  we have  determined  that our
products  are of a nature  that they are not  subject  to failure as a result of
Year 2000 issues. Although we cannot control

                                     -19-



whether and how third  parties will address the Year 2000 issue,  we also are in
the process of contacting critical vendors and suppliers to assess their ability
to ensure smooth delivery of products  without  disruptions  caused by Year 2000
problems.  In the course of our assessment,  we have not yet identified any Year
2000  issues  that  would  affect  our  ability  to do  business;  however,  our
assessment is not complete, and there can be no assurance that there are no Year
2000 issues that may affect us. Once we complete the assessment  phase,  we will
prioritize  and implement  necessary  repairs or  replacements  to equipment and
software to achieve Year 2000  compliance.  We expect to complete  this phase by
March 1999.  The final phase will consist of a testing  program for all repairs.
We anticipate that all testing will be completed by April 1999.

Costs

We have not  prepared  estimates  of  costs to  remediate  Year  2000  problems;
however, based on currently available information,  including the results of our
assessment to date and our replacement schedule for equipment, we do not believe
that the costs associated with Year 2000 compliance will have a material adverse
effect on our business, results of operations or financial condition.

Year 2000 Risks

Although we believe  that our Year 2000  compliance  plan is adequate to address
Year  2000  concerns,  there  can be no  assurance  that we will not  experience
negative consequences as a result of undetected defects or the non-compliance of
third parties with whom we interact. Furthermore, there can be no assurance that
there  will  not  be a  delay  in,  or  increased  costs  associated  with,  the
implementation  of  corrections as the Year 2000  compliance  plan is performed,
such as  unexpected  costs of correcting  equipment  that has not yet been fully
evaluated.  If realized,  these risks could  result in an adverse  effect on our
business, results of operations and financial condition.

We believe that our greatest risk stems from the potential non-compliance of our
suppliers. We depend on a limited number of suppliers for certain raw materials,
components  and  equipment  necessary  for  the  manufacture  of  our  products.
Accordingly,  if those  suppliers  are  unable to  process or fill our orders or
otherwise  interact with us because of Year 2000 problems,  we could  experience
material adverse effects to our business. We are in the process of assessing the
Year 2000 status of our suppliers and are investigating  alternative  sources of
supply.  As a consequence  of our  dependence on limited  sources of supply,  we
generally  maintain a significant  inventory of certain  critical  materials and
require  suppliers  to keep  certain  amounts  of  inventory  available  for us;
however, there can be no assurance that we will have enough materials on hand to
continue  production  without  interruption  in the  event  one or  more  of our
suppliers  experiences  Year 2000  problems  that affect its (their)  ability to
supply us. Any supply chain  disruptions would affect our ability to manufacture
our  products  which  could  result  in  material  adverse  consequences  to our
business, results of operations and financial condition.

                                     -20-



Contingencies

We have not yet developed a contingency plan to address what would happen in the
event we are unable to address  the Year 2000  issue.  The  contingency  plan is
expected  to be  completed  after  the  inquiry  of  vendors  and  customers  is
completed.

Item 3.  Quantitative and Qualitative Disclosures About Market Risk

No material  changes in market risk have been identified  during the most recent
quarter.

PART II - OTHER INFORMATION

Item 4. Submission of Matters to a Vote of Security Holders

The Company's  Annual Meeting of Shareholders  convened on November 3, 1998. The
following proposals were introduced and voted upon:

PROPOSAL NO. 1 -- Election of Directors

                                   Votes          Votes    
      Name                          For         Withheld   
      -------------------        -----------   ------------
      F. Neal Hunter             11,740,086      203,680    
      Calvin H. Carter, Jr.      11,870,286       73,480    
      John W. Palmour            11,869,286       74,480    
      Walter L. Robb             11,853,486       90,280    
      Michael W. Haley           11,738,686      205,080    
      Dolph W. von Arx           11,722,686      221,080    
      James E. Dykes             11,715,486      228,280    

PROPOSAL NO.2 -- Amendment and Restatement of Articles of Incorporation

                  FOR                         7,543,630
                  AGAINST                       595,781
                  ABSTAINED                      41,635
                  BROKER NON-VOTES            3,762,720

PROPOSAL  NO.3 -- To ratify the  selection  of Ernst & Young LLP as auditors for
the fiscal year ending June 27, 1999

                  FOR                        11,613,306
                  AGAINST                        13,091
                  ABSTAINED                      28,369
                  BROKER NON-VOTES              289,000

                                     -21-



The matters  listed above are  described in detail in the  Company's  definitive
proxy  statement  dated October 1, 1998, for the Annual Meeting of  Shareholders
held on November 3, 1998.

Item 6.  Exhibits and Reports on Form 8-K

(a)  Exhibits

     Exhibit  Description
     -------  -----------------------------------------------------------------

      10.1    Amended and Restated Equity Compensation Plan effective
              December 7, 1998

      10.16   Fourth  Amendment  to Purchase  Agreement  between the Company and
              Siemens AG dated December 16, 1998 (1)

      10.17   Second  Amended  and  Restated  Indemnity  Agreement  between  the
              Company and F. Neal Hunter dated September 25, 1998

      27      Financial Data Schedule

      99.1    Risk Factors

(b)  Reports on Form 8-K

              No  reports  on Form 8-K  were  filed by the  Company  during  the
              quarter ended December 27, 1998.





- ----------------------
(1)Confidential  treatment  of  portions  of this  document  is being  requested
   pursuant to Rule 24b-2 of the Securities and Exchange Commission.

                                     -22-



                                  SIGNATURES

Pursuant to the  requirements of Section 13 or 15(d) of the Securities  Exchange
Act of 1934,  the  registrant  has duly  caused  this report to be signed on its
behalf by the undersigned thereunto duly authorized.

                                   CREE RESEARCH, INC.

Date: January 28, 1999             /s/ Cynthia B. Merrell
                                   ----------------------------------------
                                   Cynthia B. Merrell
                                   Chief Financial Officer and Treasurer
                                   (Authorized Officer and Chief Financial
                                   and Accounting Officer)




                                     -23-